Pretplata za 2 €

Od 2 evra osigurano

Institutional-grade intelligence for professional investors

LIVE

•Real-time feeds•Global markets•24/7 coverage

Recursion Pharmaceuticals Aktie News & Pressemeldungen

Recursion Pharmaceuticals Eulerpool vesti

9. 8. 2024. 05:13:00

Pharmatech-Giganten verschmelzen: Exscientia und Recursion bündeln Kräfte

29. 8. 2024. 06:30:58

Revolution im Gesundheitswesen: Künstliche Intelligenz entlastet knappe Ressourcen

9. 9. 2024. 04:40:07

ARK-Investment: Einblicke in Cathie Woods Strategie und ihre kontroversen Entscheidungen

11. 10. 2024. 13:35:37

Ark Invest setzt auf AMD – Semiconductors im Fokus

11. 10. 2024. 14:18:07

Recursion Pharmaceuticals übernimmt Exscientia: Eine Fusion zur Beschleunigung der Wirkstoffforschung

1

2

1

2

Recursion Pharmaceuticals Akcija Vesti

Recursion Pharmaceuticals праћен је од стране многих новинара и инвеститора широм света. Најсвежије Recursion Pharmaceuticals вести окупљамо овде.

25. јул ·
Yahoo
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?
23. јул ·
Yahoo
Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note
22. јул ·
Yahoo
Recursion Pharmaceuticals (RXRX) Jumps 9.6% Ahead of Q2 Earnings
21. јул ·
Yahoo
Why Is Recursion Pharma Stock Surging On Monday?
21. јул ·
Yahoo
BC-Most Active Stocks
21. јул ·
Yahoo
Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock?
21. јул ·
Yahoo
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia
17. јул ·
Yahoo
Recursion Pharmaceuticals Rises 6% in a Month: How to Play the Stock
10. јул ·
Yahoo
Morgan Stanley Assumes Coverage of Recursion Pharmaceuticals (RXRX) Stock with an Equal Weight Rating
9. јул ·
Yahoo
Recursion Pharmaceuticals (RXRX) Rallies 8.7% on Hypophosphatasia

1

2

1

2

Recursion Pharmaceuticals акција саопштења за штампу

Recursion Pharmaceuticals redovno objavljuje na web stranici kompanije vesti koje su relevantne za investitore.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Od 2 evra osigurajте

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan